Safety and side effects of cannabidiol, a Cannabis sativa constituent.
Subject: General - PUBLISHED VIA Bentham Science Publishers
Author(s):
Bergamaschi MM, Queiroz RH, Zuardi AW, Crippa JA
View Source >>
(Price: $58)
Related Studies:
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb.
Published via Cell Press
Combined cannabinoid therapy via an oromucosal spray.
Published via Drugs Today
Pharmacology of Cannabinoids
Published via Neuroendocrinology Letters
Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
Published via Neuropsychopharmacology
Cannabinoids in clinical practice.
Published via Adis International Limited
A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol
Published via Medical Hypotheses
Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system.
Published via PLOS ONE
The therapeutic potential of cannabis and cannabinoids.
Published via Deutsches Ärzteblatt Int
The endocannabinoid system as an emerging target of pharmacotherapy.
Published via Pharmacological Reviews
Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects.
Published via Chemistry and Physics of Lipids
Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action.
Published via Revista Brasileira de Psiquiatria
Cannabidiol: an overview of some pharmacological aspects.
Published via The Journal of Clinical Pharmacology
Therapeutic potential of cannabinoid-based drugs.
Published via Advances in Experimental Medicine and Biology
Emerging strategies for exploiting cannabinoid receptor agonists as medicines.
Published via British Journal of Pharmacology
Understanding the molecular aspects of tetrahydrocannabinol and cannabidiol as antioxidants.
Published via Molecules
Advances in Experimental Medicine and Biology
Published via Philosophical Transactions of the Royal Society B
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress.
Published via Free Radical Biology and Medicine